Chloramphenicol IP/BP/USP represents pharmaceutical-grade antibiotic raw material manufactured to the highest purity standards. Presented as white or yellowish crystalline needles ...

Chloramphenicol IP/BP/USP represents pharmaceutical-grade antibiotic raw material manufactured to the highest purity standards. Presented as white or yellowish crystalline needles or long flakes with CAS number 56-75-7, this broad-spectrum antibiotic demonstrates potent activity against gram-positive, gram-negative, and most anaerobic bacteria. Its compliance with International Pharmacopoeia, British Pharmacopoeia, and United States Pharmacopeia specifications ensures consistent quality and reliability for serious pharmaceutical applications. This product serves as a crucial therapeutic agent for infections where conventional antibiotics prove ineffective, making it an essential component in medical formulations worldwide.

Pharmaceutical manufacturers across multiple sectors utilize Chloramphenicol in various therapeutic formulations. In human medicine, it's incorporated into oral tablets, capsules, and injectable solutions for treating serious systemic infections including typhoid, meningitis, and certain respiratory conditions. Veterinary pharmaceutical companies employ it in medications for bacterial diseases affecting livestock, poultry, and companion animals. Additionally, manufacturers of ophthalmic preparations value its effectiveness in eye infection treatments, while topical formulation developers use it in creams and ointments for dermatological applications. Its broad-spectrum efficacy makes it particularly valuable in regions facing antibiotic-resistant bacterial challenges.

Businesses sourcing this Chloramphenicol benefit from guaranteed quality consistency and supply reliability from established manufacturers. The product's adherence to multiple international pharmacopeial standards provides regulatory confidence for global market distribution. Its proven therapeutic effectiveness against resistant bacterial strains enhances product portfolios and supports healthcare outcomes. Manufacturers appreciate the material's consistent physical characteristics and chemical stability, which facilitate predictable formulation processes. This reliability translates to reduced production variability and strengthened partnerships between suppliers and pharmaceutical companies.

Key Features:
- Complies with IP, BP, and USP pharmacopeial standards for global regulatory acceptance.
- Appears as white or yellow crystalline needles or long flakes with consistent morphology.
- Exhibits broad-spectrum activity against gram-positive, gram-negative, and anaerobic bacteria.
- High pharmaceutical-grade purity with verified CAS number 56-75-7 identification.
- Stable crystalline form suitable for various pharmaceutical manufacturing processes.

Benefits:
- Ensures regulatory compliance for pharmaceutical products in international markets.
- Provides reliable therapeutic efficacy against diverse bacterial pathogens.
- Supports consistent manufacturing outcomes with predictable physical characteristics.
- Reduces formulation challenges through established quality and stability profiles.
- Enhances product portfolios with a proven antibiotic for serious infections.